Filter Results:
- Full text PDF available (12)
Publication Year
2003
2018
- This year (11)
- Last 5 years (35)
- Last 10 years (47)
Publication Type
Co-author
Journals and Conferences
Learn More
- Megan E. B. Clowse, Laurence S. Magder, Frank R. Witter, Michelle Petri
- Arthritis and rheumatism
- 2005
OBJECTIVE
Systemic lupus erythematosus is associated with multiple adverse pregnancy outcomes. We examined the impact of disease activity on spontaneous abortions, perinatal mortality, preterm… (More)
- Megan E. B. Clowse
- Rheumatic diseases clinics of North America
- 2007
Pregnancy in a woman with systemic lupus erythematosus (SLE) can be complicated by both lupus activity and pregnancy mishaps. The majority of recent studies found an increase in lupus activity during… (More)
- Anirudh J. Ullal, Charles F. Reich, +4 authors David S. Pisetsky
- Journal of autoimmunity
- 2011
Systemic lupus erythematosus is a prototypic autoimmune disease characterized by antibodies to DNA and other nuclear molecules. While these antibodies can form immune complexes, the mechanisms… (More)
- Megan E. B. Clowse, Margaret Jamison, E. N. Myers, Andra H. James
- American journal of obstetrics and gynecology
- 2008
OBJECTIVE
This study was undertaken to determine the risk of rare complications during pregnancy for women with systemic lupus erythematosus.
STUDY DESIGN
By using the Nationwide Inpatient Sample… (More)
- Mattia Bonsignori, Kevin Wiehe, +26 authors Barton F. Haynes
- The Journal of clinical investigation
- 2014
Broadly HIV-1-neutralizing antibodies (BnAbs) display one or more unusual traits, including a long heavy chain complementarity-determining region 3 (HCDR3), polyreactivity, and high levels of somatic… (More)
- Megan E. B. Clowse
- Best practice & research. Clinical rheumatology
- 2010
Most pregnancies in women with rheumatologic disease will result in the delivery of a healthy baby. Pregnancy can be particularly risky in women with active disease or on teratogenic medications,… (More)
- Megan E. B. Clowse, Millie A Behera, +4 authors Lori A. Bastian
- Journal of women's health
- 2009
PURPOSE
Treatment with cyclophosphamide (CYC) confers up to a 40% risk of ovarian failure in women of reproductive age. The use of GnRH agonists (GnRHa) to preserve ovarian function has been… (More)
Severe systemic lupus erythematosus often requires the use of cyclophosphamide in women of reproductive age. As cyclophosphamide is generally avoided during pregnancy because of its teratogenic risk,… (More)
- Monika E Østensen, L Andreoli, +17 authors Michael von Wolff
- Autoimmunity reviews
- 2015
Throughout the last decade, increasing awareness has been raised on issues related to reproduction in rheumatic diseases including basic research to clarify the important role of estrogens in the… (More)
- Robert D Tunks, Megan E. B. Clowse, Stephen G. Miller, Leo R. Brancazio, Piers C A Barker
- American journal of obstetrics and gynecology
- 2013
OBJECTIVE
The importance of maternal autoantibody levels in congenital heart block and elucidation of maternal factors that may reduce disease burden require further clarification.
STUDY DESIGN… (More)